Myomectomy
18
3
3
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
33%
6 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Lidocaine for LESS Postoperative Shoulder Pain Alleviation
Risk of Hysterectomy at Time of Myomectomy
Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy
Investigation of the Impact of Myomectomy on Uterine Artery Doppler Velocimetry Findings
Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
The Effect of Partial Bladder Filling on Post-operative Time to Void in Minimally Invasive Gynecologic Procedures
Intravenous Oxytocin Versus Tranexamic Acid in Reducing Blood Loss During Abdominal Myomectomy.
Tranexamic Acid Versus Vaginal Misoprostol in Abdominal Myomectomy
Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Abdominal Myomectomy
Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
Preoperative Vaginal Dinoprostone Prior to Abdominal Myomectomy
Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy With Barbed Sutures
Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy
Effect of Perioperative iv Dexmedetomidine vs. Lidocaine on Postoperative Pain, Analgesic Consumption and Recovery After Abdominal Gynaecological Surgery
Myomectomy During Cesarean Section
Uterine Tourniquet at Open Myomectomy
Improved Recovery Using Multimodal Peri-operative Analgesia in Minimally Invasive Myomectomy